4.2 Meeting Abstract

QuANTUM-First Trial: FLT3-Internal Tandem Duplication (FLT3-ITD)-Specific Measurable Residual Disease (MRD) Clearance Is Associated With Improved Overall Survival (OS)

Journal

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume 23, Issue -, Pages S272-S272

Publisher

CIG MEDIA GROUP, LP

Keywords

acute myeloid leukemia; FLT3-ITD; measurable residual disease; NGS; PCR; quizartinib; phase III

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available